NADPH Oxidase Activity in Retinal Pigmented Epithelium as a Target for Prevention of Age-related Macular Degeneration

Main Article Content

Mark F. McCarty

Abstract

Considerable evidence points to macular oxidative stress as a key driver of age-related macular degeneration (AMD).  In particular, retinal pigmented epithelial (RPE) cells subjected to oxidative stress are prone to apoptosis or senescence; lose their tight junctions; decrease their production of factors which provide trophic support for retinal photoreceptors, suppress choroidal neovascularization, and control complement activation; and boost their production of vascular endothelial growth factor (VEGF), a major stimulant to neovascularization – all effects which are consistent with the pathogenesis of AMD.  There is good reason to suspect that NADPH oxidase activity in RPE cells is the key source of the oxidative stress that compromises RPE function in AMD.   Studies with other cell lines indicate that a number of risk factors for AMD – including cigarette smoke, homocysteine, hyperglycemia, cadmium, and up-regulated activation of the alternative complement cascade – have the ability to stimulate NADPH oxidase activity, as does all-trans-retinal, a suspected pathogenic factor in AMD.  Hence, measures which can down-regulate NADPH oxidase activity may have potential for preventing or controlling AMD.  These may include high-dose statins – found to reverse features of early AMD in about half of patients in a recent pilot study – and spirulina, a rich source of the chromophore phycocyanobilin (PhyCB ).  PhyCB is a biliverdin derivative that can mimic the intracellular physiological role of bilirubin as an NADPH oxidase inhibitor.  Patients with Gilbert syndrome or relatively high plasma unconjugated bilirubin may be at lower risk for AMD owing to bilirubin’s inhibitory impact on NADPH oxidase; this prediction could be readily tested in epidemiological studies.

 

Article Details

How to Cite
MCCARTY, Mark F.. NADPH Oxidase Activity in Retinal Pigmented Epithelium as a Target for Prevention of Age-related Macular Degeneration. Medical Research Archives, [S.l.], v. 5, n. 1, jan. 2017. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/944>. Date accessed: 08 dec. 2024.
Keywords
age-related macular degeneration; NADPH oxidase; retinal pigmented epithelial cells; smoking; homcysteine; hyperglycemia; cadmium; complement
Section
Review Articles

References

References

(1) de Jong PT. Age-related macular degeneration. N Engl J Med 2006 October 5;355(14):1474-85.
(2) Wang AL, Lukas TJ, Yuan M, Du N, Tso MO, Neufeld AH. Autophagy, exosomes and drusen formation in age-related macular degeneration. Autophagy 2009 May;5(4):563-4.
(3) Anderson DH, Radeke MJ, Gallo NB et al. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res 2010 March;29(2):95-112.
(4) Despriet DD, Klaver CC, Witteman JC et al. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA 2006 July 19;296(3):301-9.
(5) Despriet DD, van Duijn CM, Oostra BA et al. Complement component C3 and risk of age-related macular degeneration. Ophthalmology 2009 March;116(3):474-80.
(6) Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000 September;45(2):115-34.
(7) Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000 September;45(2):115-34.
(8) Cai J, Nelson KC, Wu M, Sternberg P, Jr., Jones DP. Oxidative damage and protection of the RPE. Prog Retin Eye Res 2000 March;19(2):205-21.
(9) Shen JK, Dong A, Hackett SF, Bell WR, Green WR, Campochiaro PA. Oxidative damage in age-related macular degeneration. Histol Histopathol 2007 December;22(12):1301-8.
(10) Donoso LA, Vrabec T, Kuivaniemi H. The role of complement Factor H in age-related macular degeneration: a review. Surv Ophthalmol 2010 May;55(3):227-46.
(11) Bailey TA, Kanuga N, Romero IA, Greenwood J, Luthert PJ, Cheetham ME. Oxidative stress affects the junctional integrity of retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2004 February;45(2):675-84.
(12) Ohno-Matsui K, Morita I, Tombran-Tink J et al. Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF. J Cell Physiol 2001 December;189(3):323-33.
(13) Wu Z, Lauer TW, Sick A, Hackett SF, Campochiaro PA. Oxidative stress modulates complement factor H expression in retinal pigmented epithelial cells by acetylation of FOXO3. J Biol Chem 2007 August 3;282(31):22414-25.
(14) Kasahara E, Lin LR, Ho YS, Reddy VN. SOD2 protects against oxidation-induced apoptosis in mouse retinal pigment epithelium: implications for age-related macular degeneration. Invest Ophthalmol Vis Sci 2005 September;46(9):3426-34.
(15) Ohno-Matsui K, Morita I, Tombran-Tink J et al. Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF. J Cell Physiol 2001 December;189(3):323-33.
(16) Kannan R, ZHANG N, Sreekumar PG et al. Stimulation of apical and basolateral VEGF-A and VEGF-C secretion by oxidative stress in polarized retinal pigment epithelial cells. Mol Vis 2006;12:1649-59.
(17) Marazita MC, Dugour A, Marquioni-Ramella MD, Figueroa JM, Suburo AM. Oxidative stress-induced premature senescence dysregulates VEGF and CFH expression in retinal pigment epithelial cells: Implications for Age-related Macular Degeneration. Redox Biol 2016 April;7:78-87.
(18) Chucair AJ, Rotstein NP, Sangiovanni JP, During A, Chew EY, Politi LE. Lutein and zeaxanthin protect photoreceptors from apoptosis induced by oxidative stress: relation with docosahexaenoic acid. Invest Ophthalmol Vis Sci 2007 November;48(11):5168-77.
(19) Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, Kelly SP. Smoking and age-related macular degeneration: a review of association. Eye (Lond) 2005 September;19(9):935-44.
(20) Evans JR, Fletcher AE, Wormald RP. 28,000 Cases of age related macular degeneration causing visual loss in people aged 75 years and above in the United Kingdom may be attributable to smoking. Br J Ophthalmol 2005 May;89(5):550-3.
(21) Tomany SC, Wang JJ, van LR et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology 2004 July;111(7):1280-7.
(22) Espinosa-Heidmann DG, Suner IJ, Catanuto P, Hernandez EP, Marin-Castano ME, Cousins SW. Cigarette smoke-related oxidants and the development of sub-RPE deposits in an experimental animal model of dry AMD. Invest Ophthalmol Vis Sci 2006 February;47(2):729-37.
(23) Imamura Y, Noda S, Hashizume K et al. Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. Proc Natl Acad Sci U S A 2006 July 25;103(30):11282-7.
(24) Schutt F, Davies S, Kopitz J, Boulton M, Holz FG. [A retinoid constituent of lipofuscin, A2-E, is a photosensitizer in human retinal pigment epithelial cells]. Ophthalmologe 2000 October;97(10):682-7.
(25) Dontsov AE, Glickman RD, Ostrovsky MA. Retinal pigment epithelium pigment granules stimulate the photo-oxidation of unsaturated fatty acids. Free Radic Biol Med 1999 June;26(11-12):1436-46.
(26) Rozanowska M, Sarna T. Light-induced damage to the retina: role of rhodopsin chromophore revisited. Photochem Photobiol 2005 November;81(6):1305-30.
(27) Rotstein NP, Politi LE, German OL, Girotti R. Protective effect of docosahexaenoic acid on oxidative stress-induced apoptosis of retina photoreceptors. Invest Ophthalmol Vis Sci 2003 May;44(5):2252-9.
(28) Subczynski WK, Wisniewska A, Widomska J. Location of macular xanthophylls in the most vulnerable regions of photoreceptor outer-segment membranes. Arch Biochem Biophys 2010 May 27.
(29) Bone RA, Landrum JT, Mayne ST, Gomez CM, Tibor SE, Twaroska EE. Macular pigment in donor eyes with and without AMD: a case-control study. Invest Ophthalmol Vis Sci 2001 January;42(1):235-40.
(30) Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton ME. Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci 2001 February;42(2):439-46.
(31) Wustemeyer H, Jahn C, Nestler A, Barth T, Wolf S. A new instrument for the quantification of macular pigment density: first results in patients with AMD and healthy subjects. Graefes Arch Clin Exp Ophthalmol 2002 August;240(8):666-71.
(32) Miceli MV, Liles MR, Newsome DA. Evaluation of oxidative processes in human pigment epithelial cells associated with retinal outer segment phagocytosis. Exp Cell Res 1994 September;214(1):242-9.
(33) Tate DJ, Jr., Miceli MV, Newsome DA. Phagocytosis and H2O2 induce catalase and metallothionein gene expression in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1995 June;36(7):1271-9.
(34) Li Q, Dinculescu A, Shan Z et al. Downregulation of p22phox in Retinal Pigment Epithelial Cells Inhibits Choroidal Neovascularization in Mice. Mol Ther 2008 July 29.
(35) Li Q, Dinculescu A, Shan Z et al. Downregulation of p22phox in retinal pigment epithelial cells inhibits choroidal neovascularization in mice. Mol Ther 2008 October;16(10):1688-94.
(36) Bhatt L, Groeger G, McDermott K, Cotter TG. Rod and cone photoreceptor cells produce ROS in response to stress in a live retinal explant system. Mol Vis 2010;16:283-93.
(37) Usui S, Oveson BC, Lee SY et al. NADPH oxidase plays a central role in cone cell death in retinitis pigmentosa. J Neurochem 2009 August;110(3):1028-37.
(38) Velilla S, Garcia-Medina JJ, Garcia-Layana A et al. Smoking and age-related macular degeneration: review and update. J Ophthalmol 2013;2013:895147.
(39) Jaimes EA, DeMaster EG, Tian RX, Raij L. Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arterioscler Thromb Vasc Biol 2004 June;24(6):1031-6.
(40) Orosz Z, Csiszar A, Labinskyy N et al. Cigarette smoke-induced proinflammatory alterations in the endothelial phenotype: role of NAD(P)H oxidase activation. Am J Physiol Heart Circ Physiol 2007 January;292(1):H130-H139.
(41) Asano H, Horinouchi T, Mai Y et al. Nicotine- and tar-free cigarette smoke induces cell damage through reactive oxygen species newly generated by PKC-dependent activation of NADPH oxidase. J Pharmacol Sci 2012;118(2):275-87.
(42) Mai Y, Higashi T, Terada K et al. Nicotine- and tar-free cigarette smoke extract induces cell injury via intracellular Ca2+-dependent subtype-specific protein kinase C activation. J Pharmacol Sci 2012;120(4):310-4.
(43) Noya Y, Seki K, Asano H et al. Identification of stable cytotoxic factors in the gas phase extract of cigarette smoke and pharmacological characterization of their cytotoxicity. Toxicology 2013 December 6;314(1):1-10.
(44) Huang P, Wang F, Sah BK et al. Homocysteine and the risk of age-related macular degeneration: a systematic review and meta-analysis. Sci Rep 2015;5:10585.
(45) Christen WG, Glynn RJ, Chew EY, Albert CM, Manson JE. Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study. Arch Intern Med 2009 February 23;169(4):335-41.
(46) Siow YL, Au-Yeung KK, Woo CW, O K. Homocysteine stimulates phosphorylation of NADPH oxidase p47phox and p67phox subunits in monocytes via protein kinase Cbeta activation. Biochem J 2006 August 15;398(1):73-82.
(47) Signorello MG, Segantin A, Passalacqua M, Leoncini G. Homocysteine decreases platelet NO level via protein kinase C activation. Nitric Oxide 2009 March;20(2):104-13.
(48) Jakubowski H. Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans. J Nutr 2000 February;130(2S Suppl):377S-81S.
(49) Huo Y, Li J, Qin X et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. JAMA 2015 April 7;313(13):1325-35.
(50) Zhang C, Chi FL, Xie TH, Zhou YH. Effect of B-vitamin supplementation on stroke: a meta-analysis of randomized controlled trials. PLoS ONE 2013;8(11):e81577.
(51) Dong H, Pi F, Ding Z et al. Efficacy of Supplementation with B Vitamins for Stroke Prevention: A Network Meta-Analysis of Randomized Controlled Trials. PLoS ONE 2015;10(9):e0137533.
(52) Miller AA, Drummond GR, Schmidt HH, Sobey CG. NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries. Circ Res 2005 November 11;97(10):1055-62.
(53) Chen X, Rong SS, Xu Q et al. Diabetes mellitus and risk of age-related macular degeneration: a systematic review and meta-analysis. PLoS ONE 2014;9(9):e108196.
(54) Chiu CJ, Milton RC, Gensler G, Taylor A. Association between dietary glycemic index and age-related macular degeneration in nondiabetic participants in the Age-Related Eye Disease Study. Am J Clin Nutr 2007 July;86(1):180-8.
(55) Chiu CJ, Hubbard LD, Armstrong J et al. Dietary glycemic index and carbohydrate in relation to early age-related macular degeneration. Am J Clin Nutr 2006 April;83(4):880-6.
(56) Li X, Cai Y, Wang YS et al. Hyperglycaemia exacerbates choroidal neovascularisation in mice via the oxidative stress-induced activation of STAT3 signalling in RPE cells. PLoS ONE 2012;7(10):e47600.
(57) Inoguchi T, Li P, Umeda F et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000 November;49(11):1939-45.
(58) Shao B, Bayraktutan U. Hyperglycaemia promotes human brain microvascular endothelial cell apoptosis via induction of protein kinase C-ssI and prooxidant enzyme NADPH oxidase. Redox Biol 2014;2:694-701.
(59) Shao B, Bayraktutan U. Hyperglycaemia promotes cerebral barrier dysfunction through activation of protein kinase C-beta. Diabetes Obes Metab 2013 November;15(11):993-9.
(60) Xia L, Wang H, Munk S et al. High glucose activates PKC-zeta and NADPH oxidase through autocrine TGF-beta1 signaling in mesangial cells. Am J Physiol Renal Physiol 2008 December;295(6):F1705-F1714.
(61) Inoguchi T, Sonta T, Tsubouchi H et al. Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. J Am Soc Nephrol 2003 August;14(8 Suppl 3):S227-S232.
(62) Sonta T, Inoguchi T, Tsubouchi H et al. Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity. Free Radic Biol Med 2004 July 1;37(1):115-23.
(63) Sasaki S, Inoguchi T. The role of oxidative stress in the pathogenesis of diabetic vascular complications. Diabetes Metab J 2012 August;36(4):255-61.
(64) Inoguchi T, Sasaki S, Kobayashi K, Takayanagi R, Yamada T. Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes. JAMA 2007 September 26;298(12):1398-400.
(65) Nawrot TS, Staessen JA, Roels HA et al. Cadmium exposure in the population: from health risks to strategies of prevention. Biometals 2010 October;23(5):769-82.
(66) Tellez-Plaza M, Jones MR, Dominguez-Lucas A, Guallar E, Navas-Acien A. Cadmium exposure and clinical cardiovascular disease: a systematic review. Curr Atheroscler Rep 2013 October;15(10):356.
(67) Hartwig A. Cadmium and cancer. Met Ions Life Sci 2013;11:491-507.
(68) McCarty MF. Zinc and multi-mineral supplementation should mitigate the pathogenic impact of cadmium exposure. Med Hypotheses 2012 November;79(5):642-8.
(69) Engstrom KS, Vahter M, Johansson G et al. Chronic exposure to cadmium and arsenic strongly influences concentrations of 8-oxo-7,8-dihydro-2'-deoxyguanosine in urine. Free Radic Biol Med 2010 May 1;48(9):1211-7.
(70) Kippler M, Hossain MB, Lindh C et al. Early life low-level cadmium exposure is positively associated with increased oxidative stress. Environ Res 2012 January;112:164-70.
(71) Huang HB, Chen GW, Wang CJ et al. Exposure to heavy metals and polycyclic aromatic hydrocarbons and DNA damage in taiwanese traffic conductors. Cancer Epidemiol Biomarkers Prev 2013 January;22(1):102-8.
(72) Nair AR, Degheselle O, Smeets K, Van KE, Cuypers A. Cadmium-Induced Pathologies: Where Is the Oxidative Balance Lost (or Not)? Int J Mol Sci 2013;14(3):6116-43.
(73) Souza V, Escobar MC, Bucio L, Hernandez E, Gomez-Quiroz LE, Gutierrez Ruiz MC. NADPH oxidase and ERK1/2 are involved in cadmium induced-STAT3 activation in HepG2 cells. Toxicol Lett 2009 June 22;187(3):180-6.
(74) Chen L, Xu B, Liu L et al. Cadmium induction of reactive oxygen species activates the mTOR pathway, leading to neuronal cell death. Free Radic Biol Med 2011 March 1;50(5):624-32.
(75) Martinez FK, Uribe Marin BC, Souza A, V et al. Hepatocytes display a compensatory survival response against cadmium toxicity by a mechanism mediated by EGFR and Src. Toxicol In Vitro 2013 April;27(3):1031-42.
(76) Nwokocha CR, Baker A, Douglas D, McCalla G, Nwokocha M, Brown PD. Apocynin Ameliorates Cadmium-Induced Hypertension Through Elevation of Endothelium Nitric Oxide Synthase. Cardiovasc Toxicol 2013 May 24.
(77) Almenara CC, Broseghini-Filho GB, Vescovi MV et al. Chronic cadmium treatment promotes oxidative stress and endothelial damage in isolated rat aorta. PLoS ONE 2013;8(7):e68418.
(78) Mohammadi-Bardbori A, Rannug A. Arsenic, cadmium, mercury and nickel stimulate cell growth via NADPH oxidase activation. Chem Biol Interact 2014 November 10;224C:183-8.
(79) Erie JC, Good JA, Butz JA, Hodge DO, Pulido JS. Urinary cadmium and age-related macular degeneration. Am J Ophthalmol 2007 September;144(3):414-8.
(80) Junemann AG, Stopa P, Michalke B et al. Levels of aqueous humor trace elements in patients with non-exsudative age-related macular degeneration: a case-control study. PLoS ONE 2013;8(2):e56734.
(81) Wu EW, Schaumberg DA, Park SK. Environmental cadmium and lead exposures and age-related macular degeneration in U.S. adults: the National Health and Nutrition Examination Survey 2005 to 2008. Environ Res 2014 August;133:178-84.
(82) Kim EC, Cho E, Jee D. Association between blood cadmium level and age-related macular degeneration in a representative Korean population. Invest Ophthalmol Vis Sci 2014 September;55(9):5702-10.
(83) Park SJ, Lee JH, Woo SJ, Kang SW, Park KH. Five heavy metallic elements and age-related macular degeneration: Korean National Health and Nutrition Examination Survey, 2008-2011. Ophthalmology 2015 January;122(1):129-37.
(84) Kim MH, Zhao D, Cho J, Guallar E. Cadmium exposure and age-related macular degeneration. J Expo Sci Environ Epidemiol 2016 March;26(2):214-8.
(85) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001 October;119(10):1417-36.
(86) Clemons TE, Kurinij N, Sperduto RD. Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13. Arch Ophthalmol 2004 May;122(5):716-26.
(87) Thurman JM, Renner B, Kunchithapautham K et al. Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury. J Biol Chem 2009 June 19;284(25):16939-47.
(88) Cortright DN, Meade R, Waters SM, Chenard BL, Krause JE. C5a, but not C3a, increases VEGF secretion in ARPE-19 human retinal pigment epithelial cells. Curr Eye Res 2009 January;34(1):57-61.
(89) Torres M, Forman HJ. Activation of several MAP kinases upon stimulation of rat alveolar macrophages: role of the NADPH oxidase. Arch Biochem Biophys 1999 June 15;366(2):231-9.
(90) Kato M, Yamaguchi T, Tachibana A et al. An atypical protein kinase C, PKC zeta, regulates human eosinophil effector functions. Immunology 2005 October;116(2):193-202.
(91) DiScipio RG, Schraufstatter IU, Sikora L, Zuraw BL, Sriramarao P. C5a mediates secretion and activation of matrix metalloproteinase 9 from human eosinophils and neutrophils. Int Immunopharmacol 2006 July;6(7):1109-18.
(92) Daniel DS, Dai G, Singh CR et al. The reduced bactericidal function of complement C5-deficient murine macrophages is associated with defects in the synthesis and delivery of reactive oxygen radicals to mycobacterial phagosomes. J Immunol 2006 October 1;177(7):4688-98.
(93) Chen Y, Okano K, Maeda T et al. Mechanism of all-trans-retinal toxicity with implications for stargardt disease and age-related macular degeneration. J Biol Chem 2012 February 10;287(7):5059-69.
(94) Li J, Cai X, Xia Q et al. Involvement of endoplasmic reticulum stress in all-trans-retinal-induced retinal pigment epithelium degeneration. Toxicol Sci 2015 January;143(1):196-208.
(95) Haruta M, Bush RA, Kjellstrom S et al. Depleting Rac1 in mouse rod photoreceptors protects them from photo-oxidative stress without affecting their structure or function. Proc Natl Acad Sci U S A 2009 June 9;106(23):9397-402.
(96) Allikmets R. Further evidence for an association of ABCR alleles with age-related macular degeneration. The International ABCR Screening Consortium. Am J Hum Genet 2000 August;67(2):487-91.
(97) Carrizzo A, Forte M, Lembo M, Formisano L, Puca AA, Vecchione C. Rac-1 as a new therapeutic target in cerebro- and cardio-vascular diseases. Curr Drug Targets 2014;15(13):1231-46.
(98) Hong H, Zeng JS, Kreulen DL, Kaufman DI, Chen AF. Atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide in ischemic stroke. Am J Physiol Heart Circ Physiol 2006 November;291(5):H2210-H2215.
(99) Wagner AH, Kohler T, Ruckschloss U, Just I, Hecker M. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler Thromb Vasc Biol 2000 January;20(1):61-9.
(100) Whaley-Connell A, Habibi J, Nistala R et al. Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment. Hypertension 2008 February;51(2):474-80.
(101) Al-Holou SN, Tucker WR, Agron E et al. The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9. Ophthalmology 2015 December;122(12):2490-6.
(102) Gehlbach P, Li T, Hatef E. Statins for age-related macular degeneration. Cochrane Database Syst Rev 2015;2:CD006927.
(103) Barbosa DT, Mendes TS, Cintron-Colon HR et al. Age-related macular degeneration and protective effect of HMG Co-A reductase inhibitors (statins): results from the National Health and Nutrition Examination Survey 2005-2008. Eye (Lond) 2014 April;28(4):472-80.
(104) Vavvas DG, Daniels AB, Kapsala ZG et al. Regression of Some High-risk Features of Age-related Macular Degeneration (AMD) in Patients Receiving Intensive Statin Treatment. EBioMedicine 2016 March;5:198-203.
(105) Lanone S, Bloc S, Foresti R et al. Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats. FASEB J 2005 November;19(13):1890-2.
(106) Matsumoto H, Ishikawa K, Itabe H, Maruyama Y. Carbon monoxide and bilirubin from heme oxygenase-1 suppresses reactive oxygen species generation and plasminogen activator inhibitor-1 induction. Mol Cell Biochem 2006 October;291(1-2):21-8.
(107) Jiang F, Roberts SJ, Datla S, Dusting GJ. NO modulates NADPH oxidase function via heme oxygenase-1 in human endothelial cells. Hypertension 2006 November;48(5):950-7.
(108) McCarty MF. Clinical potential of Spirulina as a source of phycocyanobilin. J Med Food 2007 December;10(4):566-70.
(109) Zheng J, Inoguchi T, Sasaki S et al. Phycocyanin and phycocyanobilin from Spirulina platensis protect against diabetic nephropathy by inhibiting oxidative stress. Am J Physiol Regul Integr Comp Physiol 2013 January 15;304(2):R110-R120.
(110) Chamorro G, Perez-Albiter M, Serrano-Garcia N, Mares-Samano JJ, Rojas P. Spirulina maxima pretreatment partially protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. Nutr Neurosci 2006 October;9(5-6):207-12.
(111) Rimbau V, Camins A, Romay C, Gonzalez R, Pallas M. Protective effects of C-phycocyanin against kainic acid-induced neuronal damage in rat hippocampus. Neurosci Lett 1999 December 3;276(2):75-8.
(112) Penton-Rol G, Marin-Prida J, Pardo-Andreu G et al. C-Phycocyanin is neuroprotective against global cerebral ischemia/reperfusion injury in gerbils. Brain Res Bull 2011 August 10;86(1-2):42-52.
(113) Marin-Prida J, Pavon-Fuentes N, Llopiz-Arzuaga A et al. Phycocyanobilin promotes PC12 cell survival and modulates immune and inflammatory genes and oxidative stress markers in acute cerebral hypoperfusion in rats. Toxicol Appl Pharmacol 2013 October 1;272(1):49-60.
(114) Lin JP, Vitek L, Schwertner HA. Serum Bilirubin and Genes Controlling Bilirubin Concentrations as Biomarkers for Cardiovascular Disease. Clin Chem 2010 August 6.